In deciding whether a patient is a suitable person to undergo treatment with medicinal cannabis under a medicinal cannabis approval, the chief executive may have regard to the following—
(a) the information in the application for approval;
(b) the patient’s personal circumstances;
(c) the advice of the expert advisory panel;
(d) the advice of a specialist medical practitioner;
(e) whether the patient, in the chief executive’s reasonable opinion, will be able to comply with—(i) this Act; and(ii) the conditions proposed to apply to the approval.